Medeloop, a medical research platform, has raised $15.5 million in Series A funding led by Inovia Capital, with support from Icon Ventures, General Catalyst, Maven Ventures, and new investors like Healthier Capital, Up2 Opportunity Fund, and CFO Advisors.
The funding will help it to grow and develop further. Led by CEO Rene Caissie, Medeloop offers an AI-powered platform that automates the research processāfrom finding grants to analyzing dataāby converting medical data into a graph database for faster and deeper insights.
Read also – [Funding news] NC-based mPATH Secures $3Million in Funding
The platform includes tools for locating and applying for grants, a study platform with a mobile app for participants and a web app for researchers, a no-code analytics tool for quick data analysis, and a tool for publishing research. These integrated tools enable researchers to manage all stages of a study efficiently, from start to finish.
About Medeloop
Medeloop speeds up important discoveries by using advanced AI methods that provide clear, explainable insights, supported by a strong data connection system. It is a unique platform that links, organizes, and analyzes large amounts of health data. Medeloopās innovative AI helps researchers find biomarkers, breaking down barriers in clinical research and ultimately saving lives.